NLS Agreement

Lytix Biopharma has announced a clinical collaboration with the US-based company Iovance Biotherapeutics to evaluate Lytix’s oncolytic peptide, LTX-315, in combination with Iovance’s T cell therapy. Lytix Biopharma is focused on the development of oncolytic molecules based on research in “host defense peptides”. The company’s lead compound, LTX-315, is administrated intra-tumorally and works by inducing […]

Klaria Pharma Holding has acquired Uppsalagruppen Medical AB and the patent that protects Klaria’s drug delivery technology, it has also merged with Karessa Pharma Holding to create a focused drug development company. Klaria Pharma Holding and Karessa Pharma Holding have jointly announced that the Board of Directors of Klaria and the Board of Directors of […]

Moberg Pharma has signed a distribution agreement with DongKoo Bio & Pharma for MOB-015 in the Republic of Korea. Under the agreement DongKoo is granted exclusive rights to market and sell MOB-015 in the Republic of Korea. Moberg Pharma assumes production and supply responsibility. DongKoo will conduct registration activities in the Republic of Korea, and […]

The two companies have entered into a three-year research collaboration to jointly develop in vivo genome editing treatments for genetic diseases, including haemophilia. During collaboration, bluebird and Novo Nordisk will focus on identifying a development gene therapy candidate with the ambition of offering people with haemophilia A a lifetime free of factor replacement therapy. The […]

The company has signed a long-term global supply agreement with a subsidiary of ITM Isotopen Technologien München, Isotope Technologies Garching to ensure the supply of  no-carrier-added Lutetium-177, a key component of Betalutin for R&D, clinical and commercial uses. ITM, a biotechnology and radiopharmaceutical group of companies in the development and production of radiopharmaceuticals and radionuclides […]

AMRA has entered into an exclusive agreement with the imaging CRO (Contract Research Organization) in Japan, Micron, to guide and support pharmaceutical and research clients in Japan with clinical trials. “We are very happy to have Micron as a partner for the second largest medical market. A local partner in the sophisticated Japanese market is […]